Market News (Page 22) - TendieTensor

Market News Page 22 of 158 • 3,931 articles

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

GlobeNewswire Inc. • Dr. Raza Bokhari

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

11/24/2025 08:00 AM • Medicus Pharma is developing innovative treatments for prostate and skin cancers, including a dissolvable microneedle patch for basal cell carcinoma and a next-generation hormone deprivation therapy with reduced cardiovascular risks.

AGI - Facing production challenges from mill outage and seismic event, reduced production guidance, but completed asset sale and received unanimous 'Buy' recommendation with 36% potential upside
MDCX - Company is actively developing innovative medical treatments, expanding clinical studies, and forming strategic collaborations to address unmet medical needs in cancer treatment

#prostate cancer #skin cancer #microneedle patch #hormone therapy #basal cell carcinoma

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

GlobeNewswire Inc. • Jane Chao, Ph.D.

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

11/24/2025 08:00 AM • Ceribell obtained FDA 510(k) clearance for its ClarityⓇ algorithm, becoming the first AI-powered point-of-care EEG technology capable of detecting electrographic seizures across all patient ages, from pre-term neonates to adults.

AEM - 92% YTD performance, record Q3 earnings, reduced debt, 16 out of 17 analysts recommend buying with 18% upside potential
CBLL - Achieved significant FDA regulatory milestone, expanded technological capabilities, addressed critical unmet medical need in neonatal seizure detection

#FDA clearance #seizure detection #neonatal care #EEG monitoring #AI algorithm

ASML reports transactions under its current share buyback program

GlobeNewswire Inc. • Asml Holding N.V.

ASML reports transactions under its current share buyback program

11/24/2025 08:00 AM • ASML reported its share buyback transactions from November 17-21, 2025, repurchasing shares at varying weighted average prices between €837.81 and €905.16.

ASML - The article describes routine share buyback transactions without indicating significant positive or negative market implications, representing standard financial management activity

#share buyback #stock transactions #market regulation

Annovis Announces Two Presentations at the CTAD 2025 Conference

GlobeNewswire Inc. • Maria Maccecchini, Ph.D.

Annovis Announces Two Presentations at the CTAD 2025 Conference

11/24/2025 08:00 AM • Annovis Bio will present two research presentations at the CTAD conference, highlighting biomarker data for buntanetap in treating Alzheimer's and Parkinson's diseases, focusing on potential disease-modifying therapeutic approaches.

ANVS - Company is presenting promising research data suggesting potential breakthrough in treating neurodegenerative diseases, with biomarkers indicating potential efficacy of their drug buntanetap in addressing cognitive decline

#neurodegenerative diseases #buntanetap #Alzheimer's #Parkinson's #biomarkers #clinical trials

ProMIS Neurosciences Announces Reverse Stock Split

GlobeNewswire Inc. • Promis Neurosciences Inc.

ProMIS Neurosciences Announces Reverse Stock Split

11/24/2025 08:00 AM • ProMIS Neurosciences is implementing a one-for-twenty-five reverse stock split to address Nasdaq listing requirements and potentially increase its stock price, reducing outstanding shares from approximately 53.8 million to 2.15 million.

NVDA - Stock dropped 3% after CEO warned about potential AI competition with China
PMN - The company is taking proactive steps to maintain its Nasdaq listing by implementing a reverse stock split, which suggests financial challenges but also strategic management to address potential delisting risks

#reverse stock split #Nasdaq #stock price #listing compliance

Kaltura Recognized in Frost & Sullivan’s 2025 Global Enterprise Video Platform Market Report

GlobeNewswire Inc. • Eynav (Navi) Azaria

Kaltura Recognized in Frost & Sullivan’s 2025 Global Enterprise Video Platform Market Report

11/24/2025 08:00 AM • Kaltura has been recognized as a market leader in enterprise video platforms by Frost & Sullivan, highlighting its advanced AI capabilities and innovative 'Kaltura Genies' AI agents. The company recently acquired eSelf.ai to enhance its interactive avatar technology and strengthen its position in the AI-powered video experience market.

QCOM - Topped estimates but slid about 5% after weaker licensing revenue guidance
KLTR - Recognized as a market leader, praised for innovation, advanced AI capabilities, and strategic acquisition of eSelf.ai

#AI #video platform #enterprise technology #interactive avatars #market leadership

Metavesco Unveils Transformational OTCfi ACCESS Platform and Strategic Roadmap During High-Impact Livestream Event

Benzinga • Prnewswire

Metavesco Unveils Transformational OTCfi ACCESS Platform and Strategic Roadmap During High-Impact Livestream Event

11/24/2025 07:43 AM • Metavesco announced the launch of OTCfi ACCESS, a new investor communication platform for OTC-traded companies, with a dual-revenue model involving SaaS subscriptions and token utility requirements. The platform aims to solve communication and engagement challenges for over 17,000 OTC companies.

GOOG - Partnered with Warby Parker to develop AI-powered glasses, indicating potential technological collaboration
MVCO - Company outlined a comprehensive strategic roadmap with multiple revenue streams, clean capital structure, and potential for significant ecosystem expansion, indicating strong growth potential

#OTCfi #investor communication #OTC markets #SaaS platform #blockchain

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder

GlobeNewswire Inc. • Tonix Pharmaceuticals

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder

11/24/2025 07:00 AM • Tonix Pharmaceuticals received FDA clearance to proceed with a Phase 2 HORIZON study of TNX-102 SL, a potential new treatment for major depressive disorder, targeting 360 patients across 30 U.S. sites with planned enrollment in mid-2026.

AMD - Experienced stock price decline despite strong results
TNXP - Company is advancing a novel therapeutic approach for major depressive disorder, receiving FDA clearance and planning a pivotal clinical study with promising early signals of efficacy

#FDA #IND clearance #TNX-102 SL #major depressive disorder #clinical trial

Gaming and Leisure Properties, Inc. Declares Fourth Quarter 2025 Cash Dividend of $0.78 Per Share

GlobeNewswire Inc. • Gaming And Leisure Properties, Inc.

Gaming and Leisure Properties, Inc. Declares Fourth Quarter 2025 Cash Dividend of $0.78 Per Share

11/24/2025 07:00 AM • Gaming and Leisure Properties announced a quarterly cash dividend of $0.78 per share, payable on December 19, 2025, representing a 7.25% annual dividend yield based on the current share price.

PLTR - Slumped for third straight session, down roughly 15% since Monday's close
GLPI - Company is maintaining consistent dividend payments, showing financial stability and commitment to shareholder returns, with a slight increase from the previous quarter's dividend

#dividend #REIT #real estate #gaming properties

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire Inc. • Cardiff Oncology, Inc.

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference

11/24/2025 07:00 AM • Cardiff Oncology will participate in the Piper Sandler 37th Annual Healthcare Conference, with CEO Mark Erlander presenting on December 2, 2025, discussing their PLK1 inhibition cancer therapies and lead asset onvansertib.

CRDF - Company is presenting at a major healthcare conference, showcasing ongoing clinical trials and development of novel cancer therapies, indicating active research and potential growth

#oncology #biotechnology #cancer therapy #PLK1 inhibition #conference

Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec

GlobeNewswire Inc. • Tilray Brands, Inc.

Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec

11/24/2025 07:00 AM • Tilray Brands introduced Good Supply vape products in Québec, launching 1g 510-thread cartridges in Pineapple Express and Blue Dream strains, complying with provincial cannabis regulations.

TLRY - Expanding product offerings into a new market, demonstrating growth and regulatory compliance

#cannabis #vaping #Québec #product launch #Good Supply

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

GlobeNewswire Inc. • Fortrea

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

11/24/2025 07:00 AM • Fortrea has completed a debt tender offer, purchasing $75.7 million of its outstanding 7.500% Senior Secured Notes due 2030, reducing the principal outstanding from $570 million to $494.3 million.

PHG - Recognized as a leading company in the oxygen therapy equipment market with innovative technological solutions
FTRE - The company successfully reduced its debt, reinforced its balance sheet strength, and demonstrated disciplined financial management by using cash on hand to fund the tender offer

#debt tender offer #capital structure #senior secured notes #financial management

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswire Inc. • Cervomed Inc.

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

11/24/2025 07:00 AM • CervoMed will present new data on neflamapimod, a potential treatment for Dementia with Lewy Bodies (DLB), at the 18th Clinical Trials on Alzheimer's Disease Conference, highlighting results from their Phase 2b RewinD-LB trial.

CRVO - Company is presenting promising clinical trial results for a potential treatment of Dementia with Lewy Bodies, with plans to initiate a Phase 3 trial in 2026

#neflamapimod #dementia #Lewy Bodies #clinical trials #neurodegeneration

JPMorgan annonce des distributions en espèces pour les FNB JPMorgan

GlobeNewswire Inc. • J.P. Morgan Asset Management

JPMorgan annonce des distributions en espèces pour les FNB JPMorgan

11/24/2025 07:00 AM • J.P. Morgan Asset Management announced cash distributions for two ETFs traded on the Toronto Stock Exchange, with monthly distributions of $0.12426 and $0.21875 per share for their Active U.S. Income and Nasdaq Income ETFs.

NVDA - Stock dropped 3% after CEO warned about potential AI competition with China
NDAQ - Mentioned as an index provider, with no direct commentary about their performance or status

#ETF #cash distribution #investment #asset management

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire Inc. • Arvinas, Inc.

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

11/24/2025 07:00 AM • Arvinas will present multiple research abstracts about vepdegestrant, an investigational drug for estrogen receptor positive breast cancer, at the San Antonio Breast Cancer Symposium in December 2025. The drug is being co-developed with Pfizer and is currently under FDA review.

QCOM - Topped estimates but slid about 5% after weaker licensing revenue guidance
ARVN - Company is presenting multiple research abstracts, has collaborative partnership with Pfizer, and is advancing a promising drug through FDA review

#vepdegestrant #breast cancer #protein degradation #clinical trials #PROTAC

JPMorgan Announces Cash Distributions for the JPMorgan ETFs

GlobeNewswire Inc. • J.P. Morgan Asset Management

JPMorgan Announces Cash Distributions for the JPMorgan ETFs

11/24/2025 07:00 AM • J.P. Morgan Asset Management announced cash distributions for two ETFs trading on the Toronto Stock Exchange, with unitholders of record on December 1, 2025 receiving payments on December 5, 2025.

AMD - Experienced stock price decline despite strong results
JEPI - Routine monthly distribution of $0.12426 per unit with no significant positive or negative indicators

#ETF #cash distribution #investment #Toronto Stock Exchange

Tilray dévoile les produits de vapotage Good Supply au Québec avec l’introduction récente des produits de vapotage au Québec

GlobeNewswire Inc. • Tilray Brands, Inc.

Tilray dévoile les produits de vapotage Good Supply au Québec avec l’introduction récente des produits de vapotage au Québec

11/24/2025 07:00 AM • Tilray Brands introduces Good Supply vaping products in Quebec, offering 1g 510-threaded cartridges in Pineapple Express and Blue Dream varieties, marking a significant moment for cannabis consumers in the province.

PLTR - Slumped for third straight session, down roughly 15% since Monday's close
TLRY - Company is expanding product line, entering new market segment in Quebec, and demonstrating market leadership in cannabis consumer products

#cannabis #vapotage #Good Supply #Québec #THC #vaping products

Mike Lindell Media Corp. (MLMC) and LindellTV Announce New Chief Pentagon Reporter

GlobeNewswire Inc. • Heather Mullins

Mike Lindell Media Corp. (MLMC) and LindellTV Announce New Chief Pentagon Reporter

11/24/2025 06:00 AM • Mike Lindell Media Corp. has hired Heather Mullins as its Chief Pentagon Correspondent, bringing her background in military family and election integrity reporting to the organization's news division.

PHG - Recognized as a leading company in the oxygen therapy equipment market with innovative technological solutions
MLMC - Company is expanding its media coverage, adding a Pentagon correspondent, growing its press corps, and reporting significant monthly viewer numbers

#Pentagon #military #election integrity #journalism #conservative media

New Insights from Vividata: How Canadians Shop Black Friday and Cyber Monday

GlobeNewswire Inc. • Pat Pellegrini And Anil Rege, Vividata

New Insights from Vividata: How Canadians Shop Black Friday and Cyber Monday

11/24/2025 06:00 AM • A new Vividata study reveals Canadian shoppers are becoming more strategic, using social media, digital platforms, and value-seeking behaviors to make purchasing decisions during Black Friday and Cyber Monday.

AMZN - Most visited online retailer at 82% unique monthly visits, indicating strong consumer preference

#shopping #Black Friday #Cyber Monday #consumer behavior #digital discovery #value-seeking

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire Inc. • Zymeworks Inc.

Zymeworks Announces Participation in Upcoming Investor Conferences

11/24/2025 06:00 AM • Zymeworks Inc. will participate in two upcoming healthcare investor conferences in Miami, including one-on-one meetings and fireside chats, highlighting their biotechnology portfolio and licensed healthcare assets.

NVDA - Stock dropped 3% after CEO warned about potential AI competition with China
ZYME - Company is actively engaging with investors, showcasing its diverse pipeline of novel biotherapeutics and strategic partnerships with global biopharmaceutical companies

#biotechnology #healthcare #investor conferences #biotherapeutics #licensed assets

Enerflex Ltd. Announces the Appointment of Céline Gerson as New Independent Director

GlobeNewswire Inc. • Céline Gerson

Enerflex Ltd. Announces the Appointment of Céline Gerson as New Independent Director

11/24/2025 06:00 AM • Enerflex Ltd. announced the appointment of Céline Gerson to its Board of Directors, bringing 25 years of executive experience from Fortune 500 global manufacturing and service companies.

QCOM - Topped estimates but slid about 5% after weaker licensing revenue guidance
EFXT - Company strengthens board with experienced executive, demonstrating strategic growth and leadership development

#board appointment #executive leadership #energy infrastructure

Heineken N.V. reports the progress of transactions under its current share buyback programme

GlobeNewswire Inc. • Heineken N.V.

Heineken N.V. reports the progress of transactions under its current share buyback programme

11/24/2025 06:00 AM • Heineken N.V. reported progress on its €1.5 billion share buyback programme, repurchasing 180,750 shares on exchange at an average price of €69.14 between 17-21 November 2025, bringing total repurchases to 8,193,105 shares worth €585,844,954.

AMD - Experienced stock price decline despite strong results
HKHHY - Mentioned as a party from which shares were repurchased, with no additional context suggesting positive or negative implications

#share buyback #stock repurchase #financial transaction #investor relations

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

GlobeNewswire Inc. • Scilex Holding Company

Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds

11/24/2025 06:00 AM • Scilex Holding Company has entered into a definitive agreement to exercise existing warrants, expecting to raise approximately $20.3 million. The company will issue a new unregistered warrant to purchase additional shares and plans to use the proceeds for working capital and general corporate purposes.

PLTR - Slumped for third straight session, down roughly 15% since Monday's close
SCLX - The company is raising capital through warrant exercise, demonstrating financial strategy and potential growth opportunities in pain management products

#warrants #stock offering #financing #non-opioid pain management

Nouvelles connaissances Vividata : Le magasinage des Canadiens dans le cadre du Vendredi fou et du Cyberlundi

GlobeNewswire Inc. • Vividata

Nouvelles connaissances Vividata : Le magasinage des Canadiens dans le cadre du Vendredi fou et du Cyberlundi

11/24/2025 06:00 AM • A new Vividata consumer study reveals Canadian shopping behaviors during Black Friday and Cyber Monday, highlighting a strategic approach to purchasing that combines digital discovery, second-hand shopping, and significant discount-seeking.

AMZN - Top online retailer with 82% monthly unique digital property visits, indicating strong consumer preference

#Black Friday #Cyber Monday #online shopping #consumer behavior #social media shopping

Are MGM Stock Investors Happy, Or Did They Miss Out?

The Motley Fool • Thomas Niel

Are MGM Stock Investors Happy, Or Did They Miss Out?

11/24/2025 05:35 AM • MGM Resorts International has underperformed the S&P 500 over the past 1, 3, and 5 years, with challenges including pandemic recovery, online gaming profitability concerns, and perceptions about Las Vegas's declining appeal.

MGM - Stock has significantly underperformed S&P 500, with -17.4% 1-year return compared to S&P's 13.9%, concerns about Las Vegas market, and uncertainty in online sportsbook segment

#MGM #casino #Las Vegas #online gaming #stock performance